BMJ Best Practice

参考文献

关键文献

King CH. Schistosomiasis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2001:1341-1348.

Weerakoon KG, Gobert GN, Cai P, et al. Advances in the diagnosis of human schistosomiasis. Clin Microbiol Rev. 2015;28:939-967.

Hou XY, McManus DP, Gray DJ, et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Bull World Health Organ. 2008;86:788-795.

Inyang-Etoh PC, Ejezie GC, Useh MF, et al. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans R Soc Trop Med Hyg. 2009;103:38-44.

King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008;4:65-79.

参考文章

1.  King CH. Schistosomiasis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2001:1341-1348.

2.  Sturrock RF. The schistosomes and their intermediate hosts. In: Mahmoud AAF, ed. Schistosomiasis. London, UK: Imperial College Press; 2001:7-83.

3.  Steinmann P, Keiser J, Bos R, et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411-425.

4.  van der Werf MJ, de Vlas SJ, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003;86:125-139.

5.  King CH. Epidemiology of schistosomiasis: determinants of transmission of infection. In: Mahmoud AAF, ed. Schistosomiasis. London, UK: Imperial College Press; 2001:115-132.

6.  King CH. Disease due to Schistosoma mekongi, S intercalatum and other Schistosome species. In: Mahmoud AAF, ed. Schistosomiasis. London, UK: Imperial College Press; 2001:391-412.

7.  Lindblade KA. The epidemiology of cercarial dermatitis and its association with limnological characteristics of a northern Michigan lake. J Parasitol. 1998;84:19-23.

8.  Centers for Disease Control and Prevention. November 2012. Parasites - schistosomiasis. http://www.cdc.gov/ (last accessed 5 December 2016).

9.  Anderson RM, May RM. Infectious diseases of humans: dynamics and control. New York, NY: Oxford University Press; 1991:467-496, 507-420.

10.  Warren KS, Mahmoud AAF, Cummings P, et al. Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg. 1974;23:902-909.

11.  Colley DG, Bustinduy AL, Secor WE, et al. Human schistosomiasis. Lancet. 2014;383:2253-2264.

12.  Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis. 1995;20:280-285.

13.  Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346:1212-1220.

14.  Coutinho HM, Leenstra T, Acosta LP, et al. Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection. Am J Trop Med Hyg. 2006;75:720-726.

15.  Leenstra T, Acosta LP, Langdon GC, et al. Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1. Am J Clin Nutr. 2006;83:371-379.

16.  Wynn TA, Thompson RW, Cheever AW, et al. Immunopathogenesis of schistosomiasis. Immunol Rev. 2004;201:156-167.

17.  Kirchhoff LV, Nash TE. A case of schistosomiasis japonica: resolution of CAT-scan detected cerebral abnormalities without specific therapy. Am J Trop Med Hyg. 1984;33:1155-1158.

18.  Centers for Disease Control. Acute schistosomiasis with transverse myelitis in American students returning from Kenya. MMWR Morb Mortal Wkly Rep. 1984;33:445-447.

19.  Groeneveld AE, Marszalek WW, Heyns CF. Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa. Br J Urol. 1996;78:205-208.

20.  Schwartz E, Kozarsky P, Wilson M, et al. Schistosome infection among river rafters on Omo River, Ethiopia. J Travel Med. 2005;12:3-8.

21.  Amorosa V, Kremens D, Wolfe MS, et al. Schistosoma mansoni in family 5 years after safari. Emerg Infect Dis. 2005;11:339-341.

22.  Centers for Disease Control and Prevention. Schistosomiasis infection. 2013. http://www.dpd.cdc.gov/ (last accessed 5 December 2016).

23.  Jordan P. Schistosomiasis: the St. Lucia project. Cambridge, UK: Cambridge University Press; 1985.

24.  Wang Z, Lin C, Wang H, et al. Impact assessment of health education on schistosomiasis among high school students in wanzhou area of three gorges reservoir. CJEBM. 2012;12:274-277.

25.  Santini-Oliveira M, Coler RN, Parra J, et al. Schistosomiasis vaccine candidate Sm14/GLA-SE: phase 1 safety and immunogenicity clinical trial in healthy, male adults. Vaccine. 2016;34:586-594.

26.  Warren KS, Mahmoud AA. Algorithms in the diagnosis and management of exotic diseases: I. schistosomiasis. J Infect Dis. 1975;131:614-620.

27.  Bichler KH, Savatovsky I; the Members of the Urinary Tract Infection (UTI) Working Group of the Guidelines Office of the European Association of Urology. EAU guidelines for the management of urogenital schistosomiasis. Eur Urol. 2006;49:998-1003.

28.  Mulvihill CA, Burnett JW. Swimmer's itch: a cercarial dermatitis. Cutis. 1990;46:211-213.

29.  de Jesus AR, Silva A, Santana LB, et al. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis. 2002;185:98-105.

30.  Johnston V, Stockley JM, Dockrell D, et al. British Infection Society and the Hospital for Tropical Diseases. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. J Infect. 2009;59:1-18.

31.  Coutinho HM, McGarvey ST, Acosta LP, et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis. 2005;192:528-536.

32.  King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;65:1561-1569.

33.  Kjetland EF, Ndhlovu PD, Mduluza T, et al. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg. 2005;72:311-319.

34.  Corachan M, Valls ME, Gascon J, et al. Hematospermia: a new etiology of clinical interest. Am J Trop Med Hyg. 1994;50:580-584.

35.  Peters PAS, Kazura JW. Update on diagnostic methods for schistosomiasis. In: Mahmoud AAF, ed. Balliere's clinical tropical medicine and communicable diseases: schistosomiasis. London, UK: Bailliere Tindall; 1987:419-433.

36.  Savioli L, Hatz C, Dixon H, et al. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection. Am J Trop Med Hyg. 1990;43:289-295.

37.  Al-Sherbiny MM, Osman AM, Hancock K, et al. Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. Am J Trop Med Hyg. 1999;60:960-966.

38.  Weerakoon KG, Gobert GN, Cai P, et al. Advances in the diagnosis of human schistosomiasis. Clin Microbiol Rev. 2015;28:939-967.

39.  Ochodo EA, Gopalakrishna G, Spek B, et al. Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas. Cochrane Database Syst Rev. 2015;(3):CD009579.

40.  Ferrari TC. Involvement of central nervous system in the schistosomiasis. Mem Inst Oswaldo Cruz. 2004;99:59-62.

41.  King CL. Schistosomiasis. In: Mahmoud AAF, ed. Parasitic lung diseases. New York, NY: Marcel Dekker; 1997:135-155.

42.  El-Mahgoub S. Pelvic schistosomiasis and infertility. Int J Gynaecol Obstet. 1982;20:201-206.

43.  Pittella JE. Neuroschistosomiasis. Brain Pathol. 1997;7:649-662.

44.  Gellido CL, Onesti S, Llena J, et al. Spinal schistosomiasis. Neurology. 2000;54:527.

45.  Richter J, Correia Dacal AR, Vergetti Siqueira JG, et al. Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Trop Med Int Health. 1998;3:728-735.

46.  Bedwani R, Renganathan E, El Kwhsky F, et al. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer. 1998;77:1186-1189.

47.  King CH, Keating CE, Muruka JF, et al. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg. 1988;39:361-368.

48.  Ross AG, Vickers D, Olds GR, et al. Katayama syndrome. Lancet Infect Dis. 2007;7:218-224.

49.  Gendrel D, Kombila M, Beaudoin-Leblevec G, et al. Nontyphoidal salmonellal septicemia in Gabonese children infected with Schistosoma intercalatum. Clin Infect Dis. 1994;18:103-105.

50.  Lambertucci JR, Rayes AA, Serufo JC, et al. Schistosomiasis and associated infections. Mem Inst Oswaldo Cruz. 1998;93(suppl 1):135-139.

51.  Lengeler C, Utzinger J, Tanner M. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ. 2002;80:235-242.

52.  Swai B, Poggensee G, Mtweve S, et al. Female genital schistosomiasis as an evidence of a neglected cause for reproductive ill-health: a retrospective histopathological study from Tanzania. BMC Infect Dis. 2006;6:134.

53.  Richter J, Hatz C, Campagne G, et al. Ultrasound in schistosomiasis: a practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis-related morbidity. Geneva: World Health Organization; 2000.

54.  van Velthuysen ML, Florquin S. Glomerulopathy associated with parasitic infections. Clin Microbiol Rev. 2000;13:55-66.

55.  Forsyth DM, Bradley DJ, McMahon J. Death attributed to kidney failure in communities with endemic urinary schistosomiasis. Lancet. 1970;2:472-473.

56.  Gordon MA, Zijlstra EE, Naus CW, et al. Schistosomiasis does not contribute to death or recurrence of nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected Malawian adults. Clin Infect Dis. 2003;37:e177-e179.

57.  Moore TA, McCarthy JS. Toxocariasis and larva migrans syndromes. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases, principles, pathogens and practice. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2006:1209-1216.

58.  King CH, Magak P, Salam EA, et al. Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health. 2003;8:109-117.

59.  King CH. Ultrasound monitoring of structural urinary tract disease in Schistosoma haematobium infection. Mem Inst Oswaldo Cruz. 2002;97(suppl 1):149-152.

60.  Means AR, Burns P, Sinclair D, et al. Antihelminthics in helminth-endemic areas: effects on HIV disease progression. Cochrane Database Syst Rev. 2016;(4):CD006419.

61.  Utzinger J, Xiao SH, Tanner M, et al. Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs. 2007;8:105-116.

62.  Hatz C, Mayombana C, de Savigny D, et al. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel. Trans R Soc Trop Med Hyg. 1990;84:84-88.

63.  Danso-Appiah A, Olliaro PL, Donegan S, et al. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev. 2013;(2):CD000528.

64.  King CH, Olbrych SK, Soon M, et al. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis. 2011;5:e1321.

65.  Utzinger J, Keiser J, Shuhua X, et al. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother. 2003;47:1487-1495.

66.  Kramer CV, Zhang F, Sinclair D, et al. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2014;(8):CD000053.

67.  Olveda RM, Acosta LP, Tallo V, et al. Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2016;16:199-208.

68.  Allen HE, Crompton DW, de Silva N, et al. New policies for using anthelmintics in high risk groups. Trends Parasitol. 2002;18:381-382.

69.  World Health Organization. Preventive chemotherapy in human helminthiasis: coordinated use of anthelmintic drugs in control interventions: a manual for health professionals and programme managers. Geneva, Switzerland: WHO Press; 2006.

70.  King CH, Mahmoud AA. Drugs five years later: praziquantel. Ann Intern Med. 1989;110:290-296.

71.  Liu R, Dong HF, Guo Y, et al. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors. 2011;4:201.

72.  Hua HY, Liang YS, Zhang Y, et al. The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China. Parasitol Res. 2010;107:873-878.

73.  Obonyo CO, Muok EM, Mwinzi PN. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis. 2010;10:603-611.

74.  Pérez del Villar L, Burguillo FJ, López-Abán J, et al. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS One. 2012;7:e45867.

75.  Utzinger J, N'Goran EK, N'Dri A, et al. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet. 2000;355:1320-1325.

76.  Hou XY, McManus DP, Gray DJ, et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Bull World Health Organ. 2008;86:788-795.

77.  Inyang-Etoh PC, Ejezie GC, Useh MF, et al. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans R Soc Trop Med Hyg. 2009;103:38-44.

78.  King CH, Muchiri E, Ouma JH, et al. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg. 1991;45:498-508.

79.  Abdel-Salam E, Ehsan A. Cystoscopic picture of Schistosoma haematobium in Egyptian children correlated to intensity of infection and morbidity. Am J Trop Med Hyg. 1978;27:774-778.

80.  Barrou B, Bitker MO, Boyer C, et al. Results of renal transplantation in patients with Schistosoma infection. J Urol. 1997;157:1232-1235.

81.  Abdel-Wahab MF, Ramzy I, Esmat G, et al. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures. J Urol. 1992;148:346-350.

82.  Christie JD, Crouse D, Kelada AB, et al. Patterns of Schistosoma haematobium egg distribution in the human lower urinary tract. III. Cancerous lower urinary tracts. Am J Trop Med Hyg. 1986;35:759-764.

83.  el-Bolkainy MN, Chu EW, Ghoneim MA, et al. Cytologic detection of bladder cancer in a rural Egyptian population infested with schistosomiasis. Acta Cytol. 1982;26:303-310.

84.  Badalament RA. Is the role of cystoscopy in the detection of bladder cancer really declining? J Urol. 1998;159:399-400.

85.  Coutinho HM, Acosta LP, McGarvey ST, et al. Nutritional status improves after treatment of Schistosoma japonicum-infected children and adolescents. J Nutr. 2006;136:183-188.

86.  King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008;4:65-79.

87.  AbouZahr C, Vaughan JP. Assessing the burden of sexual and reproductive ill-health: questions regarding the use of disability-adjusted life years. Bull World Health Organ. 2000;78:655-666.

88.  Khalaf I, Shokeir A, Shalaby M. Urologic complications of genitourinary schistosomiasis. World J Urol. 2012;30:31-38.

89.  Elmasalme FN, Raheem MA, Badawy A, et al. Rectosigmoid bilharzioma causing intestinal obstruction. J Pediatr Surg. 1997;32:631-633.

90.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2001. A 31-year-old man with an apparent seizure and a mass in the right parietal lobe. N Engl J Med. 2001;345:126-131.

91.  Lambertucci JR, Silva LC, do Amaral RS. Guidelines for the diagnosis and treatment of schistosomal myeloradiculopathy. Rev Soc Bras Med Trop. 2007;40:574-581.

92.  Assaré RK, Tian-Bi YN, Yao PK, et al. Sustaining control of Schistosomiasis mansoni in Western Côte d'Ivoire: results from a SCORE study, one year after initial praziquantel administration. PLoS Negl Trop Dis. 2016;10:e0004329.

使用此内容应接受我们的免责声明